SYDNEY, AUSTRALIA: Healius (ASX: HLS) has entered into an agreement to acquire the entire issued capital of Agilex, one of Australia’s leading bioanalytical laboratories. The transaction values Agilex at an enterprise value of $301.3 million.The acquisition is subject to minimal conditions, customary for a transaction of this nature, and is expected to complete at the…